The Generic Oncology Drugs Market to Grow Through the Digitized GroovePosted by Steve Sharma on December 21st, 2021 Sales revenue from generic oncology drugs in 2020 was US$ 23 Bn, which is expected to surge to US$ 41.5 Bn by the end of 2031. Analysts at Persistence Market Research have also predicted the market to rise at a healthy CAGR of 6% over the next ten years. Instances of cancer cases have risen exponentially across the globe. From diagnosis to treatment, all aspects of the disease are being researched extensively by numerous market players. Persistence Market Research, a research and consulting firm, has published a new market research report on the global generic oncology drugs market that contains industry analysis of 2016–2020 and opportunity assessment for 2021–2031. Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/25480 Like it? Share it! More by this author |